513 related articles for article (PubMed ID: 11867759)
21. Knockdown of p53 levels in human keratinocytes accelerates Mcl-1 and Bcl-x(L) reduction thereby enhancing UV-light induced apoptosis.
Chaturvedi V; Sitailo LA; Qin JZ; Bodner B; Denning MF; Curry J; Zhang W; Brash D; Nickoloff BJ
Oncogene; 2005 Aug; 24(34):5299-312. PubMed ID: 15940268
[TBL] [Abstract][Full Text] [Related]
22. Neural precursor cell apoptosis and glial tumorigenesis following transplacental ethyl-nitrosourea exposure.
Leonard JR; D'Sa C; Klocke BJ; Roth KA
Oncogene; 2001 Dec; 20(57):8281-6. PubMed ID: 11781843
[TBL] [Abstract][Full Text] [Related]
23. Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells.
Ramalho RM; Borralho PM; Castro RE; Solá S; Steer CJ; Rodrigues CM
J Neurochem; 2006 Sep; 98(5):1610-8. PubMed ID: 16923170
[TBL] [Abstract][Full Text] [Related]
24. Papillomavirus E2 induces p53-independent apoptosis in HeLa cells.
Desaintes C; Goyat S; Garbay S; Yaniv M; Thierry F
Oncogene; 1999 Aug; 18(32):4538-45. PubMed ID: 10467398
[TBL] [Abstract][Full Text] [Related]
25. Bax accelerates tumorigenesis in p53-deficient mice.
Knudson CM; Johnson GM; Lin Y; Korsmeyer SJ
Cancer Res; 2001 Jan; 61(2):659-65. PubMed ID: 11212265
[TBL] [Abstract][Full Text] [Related]
26. The synthetic retinoid CD437 selectively induces apoptosis in human lung cancer cells while sparing normal human lung epithelial cells.
Sun SY; Yue P; Chen X; Hong WK; Lotan R
Cancer Res; 2002 Apr; 62(8):2430-6. PubMed ID: 11956107
[TBL] [Abstract][Full Text] [Related]
27. Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis.
Marin MC; Hsu B; Meyn RE; Donehower LA; el-Naggar AK; McDonnell TJ
Oncogene; 1994 Nov; 9(11):3107-12. PubMed ID: 7936633
[TBL] [Abstract][Full Text] [Related]
28. T cells from baxalpha transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage-induced cell death in the absence of p53.
Brady HJ; Salomons GS; Bobeldijk RC; Berns AJ
EMBO J; 1996 Mar; 15(6):1221-30. PubMed ID: 8635454
[TBL] [Abstract][Full Text] [Related]
29. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
[TBL] [Abstract][Full Text] [Related]
30. [p53].
Takahashi R
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1381-5. PubMed ID: 9309129
[TBL] [Abstract][Full Text] [Related]
31. Dominant-negative p53 mutations in rheumatoid arthritis.
Han Z; Boyle DL; Shi Y; Green DR; Firestein GS
Arthritis Rheum; 1999 Jun; 42(6):1088-92. PubMed ID: 10366100
[TBL] [Abstract][Full Text] [Related]
32. Tissue-specific induction of p53 targets in vivo.
Fei P; Bernhard EJ; El-Deiry WS
Cancer Res; 2002 Dec; 62(24):7316-27. PubMed ID: 12499275
[TBL] [Abstract][Full Text] [Related]
33. [Generation and analyses of transgenic mice containing mutant p53 transgene].
Hosokawa A
Fukuoka Igaku Zasshi; 1999 Mar; 90(3):80-7. PubMed ID: 10339928
[TBL] [Abstract][Full Text] [Related]
34. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
Crowe DL; Sinha UK
Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
[TBL] [Abstract][Full Text] [Related]
35. Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells.
Li J; Zhang X; Sejas DP; Pang Q
Leuk Res; 2005 Dec; 29(12):1415-23. PubMed ID: 15964625
[TBL] [Abstract][Full Text] [Related]
36. p53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation.
Schuler M; Maurer U; Goldstein JC; Breitenbücher F; Hoffarth S; Waterhouse NJ; Green DR
Cell Death Differ; 2003 Apr; 10(4):451-60. PubMed ID: 12719722
[TBL] [Abstract][Full Text] [Related]
37. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
[TBL] [Abstract][Full Text] [Related]
38. Cytoplasmic mutant p53 increases Bcl-2 expression in estrogen receptor-positive breast cancer cells.
Pratt MA; White D; Kushwaha N; Tibbo E; Niu MY
Apoptosis; 2007 Apr; 12(4):657-69. PubMed ID: 17252199
[TBL] [Abstract][Full Text] [Related]
39. P53-dependent and -independent links between DNA-damage, apoptosis and mutation frequency in ES cells.
Corbet SW; Clarke AR; Gledhill S; Wyllie AH
Oncogene; 1999 Feb; 18(8):1537-44. PubMed ID: 10102623
[TBL] [Abstract][Full Text] [Related]
40. Oncogenic mutation of the p53 gene derived from head and neck cancer prevents cells from undergoing apoptosis after DNA damage.
Kawamata H; Omotehara F; Nakashiro K; Uchida D; Shinagawa Y; Tachibana M; Imai Y; Fujimori T
Int J Oncol; 2007 May; 30(5):1089-97. PubMed ID: 17390010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
